Hims & Hers Health has reported strong quarterly results and improved profits, leading to a stock snapback. The company is moving into AI-based medical services and weight loss management to address s
Hims & Hers Health raised its guidance once again when it reported its Q3 results. The company saw significant growth in subscribers, particularly in the mental health and women's health sectors. HIMS
SentinelOne keeps delivering cutting-edge tech and strong growth. Roku is an entrenched streaming leader with future growth ahead.
Hims & Hers Health is a telemedicine company specializing in a variety of treatments. The company's unique subscription model has helped propel strong top-line growth and margin expansion.

Ozempic vs. Mounjaro:: Battle of the bulge

10:16am, Monday, 04'th Dec 2023
The year 2023 was a breakout year for glucagon-like peptide (GLP-1) weight-loss drugs in the medical sector, led by the popularity of Ozempic. Celebrity usage and social media exposure have caused Nov
Hims & Hers Health exhibits similarities to previous "100 Bagger" stocks, which I believe the market has not noticed at all. I wanted to bring this to the forefront. The company has the potential to b

This Growth Stock Could 10x in 10 Years

08:30am, Wednesday, 29'th Nov 2023
Hims & Hers Health has performed at a high level since going public. The company is nearly profitable despite investing heavily for revenue growth.
E-health and wellness platform operator Hims & Hers Inc. NASDAQ: HIMS reported a stellar quarter of growth. The company has expanded its medical offerings well beyond offering discrete erectile dysfun
The telehealth sector is undergoing a significant transformation, reshaping the traditional contours of medical service delivery. This innovation-driven domain is drawing attention from investors, as
The stock market has performed well in recent weeks. Rising stock prices make finding good deals harder.
Well-chosen stocks can help you build lasting wealth. Read on to see how you could profit from the AI boom, as well as the shift toward more personalized healthcare.
Finding a great small-cap stock to buy isn't always easy. We know that, over the long run, small-cap stocks as a whole outperform large-cap cousins.

Is Hims & Hers Stock a Buy Now?

06:15am, Thursday, 16'th Nov 2023
Hims & Hers reported another strong quarter this month as its growth rate remains above 50%. The company raised its forecast for the year as well.
The company reported another good quarter and announced a buyback. Is HIMS stock a buy?
Hims & Hers Health, Inc. (NYSE:HIMS ) Q3 2023 Earnings Conference Call November 6, 2023 5:00 PM ET Company Participants Alice Lopatto - VP, IR Andrew Dudum - Co-Founder, Chairman & CEO Yemi Okupe - CF
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE